2 terminated. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Terminated 2 |
Follow Chromosome Disorders: new trials by email Literature Review of Chromosome Disorders trials Research Report on Chromosome Disorders
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Use of Liquid Stable Levothyroxine in Trisomy 21 Pediatric Patients Liquid stable levothyroxine (L-T4) Tirosint-SOL, Oral tablet levothyroxine (L-T4) - Hypothyroidism, Trisomy 21 | Phase 4 | Terminated | Children's Mercy Hospital Kansas City | 6 | 2021-01-18 | 2023-09-13 |
| Liraglutide Use in Prader-Willi Syndrome Liraglutide - Diabetes Mellitus Type 2, Prader Willi Syndrome | Phase 4 | Terminated | Vancouver General Hospital | 1 | 2012-02-01 | 2015-12-09 |
Diabetes Mellitus, Type 2 (1) · Down Syndrome (1) · Hypothyroidism (1) · Prader-Willi Syndrome (1)
Abnormalities, Multiple (2) · Congenital Abnormalities (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Endocrine System Diseases (2) · Genetic Diseases, Inborn (2) · Intellectual Disability (2) · Nervous System Diseases (2) · Neurobehavioral Manifestations (2) · Neurologic Manifestations (2) · Diabetes Mellitus (1) · Glucose Metabolism Disorders (1) · Imprinting Disorders (1) · Metabolic Diseases (1) · Nutrition Disorders (1)
Liraglutide (1) · Thyroxine (1)
Children's Mercy Hospital Kansas City (1) · Vancouver General Hospital (1)
Canada (1) · United States (1)